Molecular Screening In Blastic Plasmacytoid Dendritic Cell Neoplasms Reveals Mutations In TET2 and ASXL1 In The Majority Of Patients

被引：1
|
作者：
Kern, Wolfgang
Kuznia, Sabrina
Schnittger, Susanne
Haferlach, Claudia
Haferlach, Torsten
Kohlmann, Alexander
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2581.2581
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2581
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mutations in ASXL1 and/or TET2 Identify a Subset with Worse Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasms
    Xu, Mina
    Thakkar, Devang
    Panse, Gauri
    Yan, Jiong
    Minden, Mark
    Zandi, Sasan
    Naresh, Kikkeri
    Czader, Magdalena
    Love, Cassandra
    Happ, Lanie
    Koff, Jean
    Jaye, David
    Michael, Churnetski
    Arildsen, Mary Ann
    Juskevicius, Ridas
    Soliman, Dina
    Louissaint, Abner
    Mckinney, Matthew
    Sojitra, Payal
    Yin, C. Cameron
    Ondrejka, Sarah
    Tse, Eric
    Dave, Sandeep
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1258 - S1259
  • [2] Biallelic TET2 mutations and canonical ASXL1 mutations are frequent and cooccur in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): An institutional experience and review of literature
    Zhang, Xi
    Hsi, Eric D.
    Crane, Genevieve M.
    Cheng, Yu-Wei
    EJHAEM, 2023, 4 (01): : 236 - 240
  • [3] Role of TET2 and ASXL1 Mutations in the Pathogenesis of Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Mu, Ayalew Tefferi
    Levine, Ross L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1053 - +
  • [4] TET2 and ASXL1 Mutations in Leukemic Transformation of Chronic Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Patel, Jay
    Harris, Kelly
    Yao, Jin Juan
    Hedvat, Cyrus V.
    Heguy, Adriana
    Bueso-Ramos, Carlos
    Kantarjian, Hagop M.
    Levine, Ross L.
    Verstovsek, Srdan
    BLOOD, 2009, 114 (22) : 1130 - 1131
  • [5] Mutations of ASXL1 and TET2 in aplastic anemia
    Huang, Jinbo
    Ge, Meili
    Lu, Shihong
    Shi, Jun
    Li, Xingxin
    Zhang, Jizhou
    Wang, Min
    Yu, Wei
    Shao, Yingqi
    Huang, Zhendong
    Zhang, Jing
    Nie, Neng
    Zheng, Yizhou
    HAEMATOLOGICA, 2015, 100 (05)
  • [6] TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
    Beird, Hannah
    Yin, C. Cameron
    Khoury, Joseph D.
    Pierce, Sherry
    Abbas, Hussein A.
    Zhao, Li
    Skwarska, Anna
    Qazilbash, Muzaffar
    Konopleva, Marina
    Futreal, P. Andrew
    Pemmaraju, Naveen
    BLOOD ADVANCES, 2023, 7 (10) : 2000 - 2003
  • [7] Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
    Szpurka, Hadrian
    Jankowska, Anna M.
    Makishima, Hideki
    Bodo, Juraj
    Bejanyan, Nelli
    Hsi, Eric D.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    LEUKEMIA RESEARCH, 2010, 34 (08) : 969 - 973
  • [8] DNMT3A, TET2, and ASXL1 (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms
    Haran, Arnon
    Wasserstrom, Avital
    Aumann, Shlomzion
    Vainstein, Vladimir
    Kazoom, Romi
    Jelinek, Batia Roth
    Arad, Ariela
    Buchman, Noa
    Shai, Ela
    Kalish, Yossi
    Gatt, Moshe E.
    Zimran, Eran
    BLOOD, 2024, 144 : 3189 - 3190
  • [9] TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm
    Jardin, Fabrice
    Ruminy, Philippe
    Parmentier, Francoise
    Troussard, Xavier
    Vaida, Iona
    Stamatoullas, Aspasia
    Lepretre, Stephane
    Penther, Dominique
    Duval, Anne B.
    Picquenot, Jean-Michel
    Courville, Philippe
    Capiod, Jean-Claude
    Tilly, Herve
    Bastard, Christian
    Marolleau, Jean P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (03) : 413 - 416
  • [10] TET2, ASXL1, IDH1 AND IDH2 MUTATIONS IN NON-CML MYELOPROLIFERATIVE NEOPLASMS
    Soyer, N. Akad
    Kaymaz, B. Tezcanli
    Ozkan, M. Comert
    Aktan, C.
    Sahin, F.
    Kosova, B.
    Saydam, G.
    LEUKEMIA RESEARCH, 2014, 38 : S46 - S47
12345